Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
RESEARCH TOOLSreports
Holding GB:0K1R?
Track your performance easily
See the Price Targets and Ratings of:
0K1R Analyst Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0K1R Stock 12 Month Forecast
Average Price Target
$41.64
▲(111.16% Upside)
| Highest Price Target$61.00 | Average Price Target$41.64 | Lowest Price Target$27.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Downgraded
12/19/24
RBC Capital
Reiterated
12/17/24
Oppenheimer
Reiterated
12/17/24
Leerink Partners
Reiterated
12/16/24
LifeSci Capital
Reiterated
12/16/24
H.C. Wainwright
Reiterated
12/16/24
BTIG
Reiterated
12/16/24
Wedbush
Reiterated
12/16/24
Needham
Reiterated
12/16/24
TD Cowen
Reiterated
12/16/24
JMP Securities
$40→$42
Buy
112.98%
Upside
Reiterated
12/16/24
Viridian Therapeutics' Veligrotug Shows Best-in-Class Potential in Phase 3 THRIVE-2 Trial for Chronic TED
Goldman Sachs
$31→$35
Buy
77.48%
Upside
Reiterated
11/13/24
Viridian Therapeutic (VRDN) PT Raised to $35 at Goldman SachsGoldman Sachs analyst Richard Law raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $35.00 (from $31.00) while maintaining a Buy rating.
Jefferies
$45
Buy
128.19%
Upside
Assigned
11/13/24
Jefferies Releases a Buy Rating on Viridian Therapeutics (VRDN)
Stifel Nicolaus
$40→$41
Buy
107.91%
Upside
Reiterated
11/12/24
Viridian Therapeutic (VRDN) PT Raised to $41 at StifelStifel analyst Alex Thompson raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $41.00 (from $40.00) while maintaining a Buy rating.
B.Riley Financial
$20→$22
Hold
11.56%
Upside
Reiterated
09/11/24
Viridian Therapeutic (VRDN) PT Raised to $22 at B.RileyB.Riley analyst Kalpit Patel raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $22.00 (from $20.00) while maintaining a Neutral rating.
Best Analysts Covering Viridian Therapeutics
Which Analyst Should I Follow If I Want to Buy GB:0K1R and Sell After:
1 Month
xxx
Success Rate
13/26 ratings generated profit
Average Return
+5.54%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +5.54% per trade.
3 Months
xxx
Success Rate
13/23 ratings generated profit
Average Return
+4.42%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.52% of your transactions generating a profit, with an average return of +4.42% per trade.
1 Year
Success Rate
21/37 ratings generated profit
Average Return
+6.10%
reiterated a buy rating 12 days ago
Copying Laura Chico's trades and holding each position for 1 Year would result in 56.76% of your transactions generating a profit, with an average return of +6.10% per trade.
2 Years
xxx
Success Rate
15/26 ratings generated profit
Average Return
+4.39%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.69% of your transactions generating a profit, with an average return of +4.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0K1R Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
32
36
32
31
28
Buy
2
4
4
5
4
Hold
2
2
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
42
38
37
33
Each month's total comprises the sum of three months' worth of ratings.
0K1R Financial Forecast
0K1R Stock Forecast FAQ
What is GB:0K1R’s average 12-month price target, according to analysts?
Based on analyst ratings, Viridian Therapeutics’s 12-month average price target is $41.64.
What is GB:0K1R’s upside potential, based on the analysts’ average price target?
Viridian Therapeutics has 111.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Viridian Therapeutics a Buy, Sell or Hold?
Viridian Therapeutics has a consensus rating of Strong Buy, which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Viridian Therapeutics’s share price target?
The average share price target for Viridian Therapeutics is $41.64. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $61.00 ,and the lowest forecast is $27.00. The average share price target represents 111.16% Increase from the current price of $19.72.
The highest analyst share price target is $61.00 ,and the lowest forecast is $27.00. The average share price target represents 111.16% Increase from the current price of $19.72.
What do analysts say about Viridian Therapeutics?
Viridian Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of Viridian Therapeutics?
To buy shares of GB:0K1R, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.